Screening for type 2 diabetes in a high-risk population: Effects of a negative screening test after 4 years follow-up

Annals of Behavioral Medicine

Volumn 47, Issue 1, 2014, Pages 102-110

  Willems, Julie I ^a   Otto, Suzie J ^a   Klijs, Bart ^a   De Koning, Harry J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Diabetes; Lifestyle; Reassurance; Risk perception; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HUMAN; LIFESTYLE; MALE; MASS SCREENING; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK; RISK REDUCTION; SMOKING; WAIST CIRCUMFERENCE;

ADULT; AGED; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; MALE; MASS SCREENING; MIDDLE AGED; RISK; RISK REDUCTION BEHAVIOR; SMOKING; WAIST CIRCUMFERENCE;

EID: 84894454428     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12160-013-9525-3     Document Type: Article

References (64)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.
2. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ. 2000;321:405-412. (Pubitemid 30609442)
3. Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM. Cause-specific mortality in a population with diabetes: South Tees Diabetes Mortality Study. Diabetes Care. 2002;25:43-48. (Pubitemid 41070781)
4. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care. 1992;15:815-819.
5. World Health Organization. Screening for type 2 diabetes - Report of a World Health Organization and International Diabetes Federation meeting. Geneva: WHO-Department of Noncommunicable Disease Management; 2003.
6. Health Council of the Netherlands: Screening for type 2 diabetes No. publication no. 2004/16. The Hague: Health Council of the Netherlands, 2004.
7. American Diabetes A. Standards of medical care in diabetes - 2007. Diabetes Care. 2007;30(Suppl 1):S4-S41. (Pubitemid 46048398)
8. Alberti KG, Zimmet P, Shaw J. International Diabetes Federation: A consensus on type 2 diabetes prevention. Diabet Med. 2007;24:451-463. (Pubitemid 46669328)
9. Waugh N, Scotland G, McNamee P, et al. Screening for type 2 diabetes: Literature review and economic modelling. Health Technol Assess. 2007;11(iii-iv, ix-xi):1-125.
10. Norris SL, Kansagara D, Bougatsos C, Fu R, Force USPST. Screening adults for type 2 diabetes: A review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;148:855-868. (Pubitemid 351786934)
11. Eriksson J, Lindström J, Tuomilehto J: Potential for the prevention of type 2 diabetes. Br Med Bull. 2001, 60.
12. Gillies CL, Abrams KR, Lambert PC, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: Systematic review and meta-analysis. BMJ. 2007;334:299. (Pubitemid 46293963)
13. Gillett M, Royle P, Snaith A, et al. Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: A systematic review and economic evaluation. Health Technol Assess. 2012;16:1-236.
14. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343-1350. (Pubitemid 32378388)
15. Lindstrom J, Ilanne-Parikka P, Peltonen M, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: Follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673-1679. (Pubitemid 46048554)
16. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: A 20-year follow-up study. Lancet. 2008;371:1783-1789. (Pubitemid 351697954)
17. Diabetes Prevention Program Research G, Knowler WC, Fowler SE, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677-1686.
18. Echouffo-Tcheugui JB, Ali MK, Griffin SJ, Narayan KM. Screening for type 2 diabetes and dysglycemia. Epidemiol Rev. 2011;33:63-87.
19. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Impact of diabetes screening on quality of life. Diabetes Care. 2002;25:1022-1026. (Pubitemid 41110488)
20. Skinner TC, Davies MJ, Farooqi AM, et al. Diabetes screening anxiety and beliefs. Diabet Med. 2005;22:1497-1502. (Pubitemid 41641155)
21. Adriaanse MC, Snoek FJ. The psychological impact of screening for type 2 diabetes. Diabetes Metab Res Rev. 2006;22:20-25. (Pubitemid 43154457)
22. Thoolen BJ, de Ridder DT, Bensing JM, Gorter KJ, Rutten GE. Psychological outcomes of patients with screen-detected type 2 diabetes: The influence of time since diagnosis and treatment intensity. Diabetes Care. 2006;29:2257-2262. (Pubitemid 44899862)
23. Eborall HC, Griffin SJ, Prevost AT, et al. Psychological impact of screening for type 2 diabetes: Controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ. 2007;335:486. (Pubitemid 47401608)
24. Park P, Simmons RK, Prevost AT, Griffin SJ. Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: A randomised controlled trial in British general practice. BMC Publ Health. 2008;8:350.
25. Stewart-Brown S, Farmer A. Screening could seriously damage your health. BMJ. 1997;314:533-534. (Pubitemid 27089368)
26. Eborall H, Davies R, Kinmonth AL, Griffin S, Lawton J. Patients' experiences of screening for type 2 diabetes: Prospective qualitative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ. 2007;335:490. (Pubitemid 47401609)
27. Bankhead CR, Brett J, Bukach C, et al. The impact of screening on future health-promoting behaviours and health beliefs: A systematic review. Health Technol Assess. 2003;7:1-92.
28. van der Aalst CM, van Klaveren RJ, de Koning HJ. Does participation to screening unintentionally influence lifestyle behaviour and thus lifestyle-related morbidity? Best Pract Res Clin Gastroenterol. 2010;24:465-478.
29. Deutekom M, Vansenne F, McCaffery K, et al. The effects of screening on health behaviour: A summary of the results of randomized controlled trials. J Public Health (Oxf). 2011;33:71-79.
30. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: The case of smoking cessation. Health Educ Res. 2003;18:156-170. (Pubitemid 36457244)
31. Tymstra T, Bieleman B. The psychosocial impact of mass screening for cardiovascular risk factors. Fam Pract. 1987;4:287-290. (Pubitemid 17165026)
32. Ostroff JS, Buckshee N, Mancuso CA, Yankelevitz DF, Henschke CI. Smoking cessation following CT screening for early detection of lung cancer. Prev Med. 2001;33:613-621. (Pubitemid 34101886)
33. Miles A, Wardle J, McCaffery K, Williamson S, Atkin W. The effects of colorectal cancer screening on health attitudes and practices. Cancer Epidemiol Biomark Prev. 2003;12:651-655. (Pubitemid 36899847)
34. Larsen IK, Grotmol T, Almendingen K, Hoff G. Impact of colorectal cancer screening on future lifestyle choices: A three-year randomized controlled trial. Clin Gastroenterol Hepatol. 2007;5:477-483. (Pubitemid 46584834)
35. Paddison CA, Eborall HC, Sutton S, et al. Are people with negative diabetes screening tests falsely reassured? Parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ. 2009;339:b4535.
36. van der Aalst CM, van Klaveren RJ, van den Bergh KA, Willemsen MC, de Koning HJ. The impact of a lung cancer computed tomography screening result on smoking abstinence. Eur Respir J. 2011;37:1466-1473.
37. Brewer NT, Weinstein ND, Cuite CL, Herrington JE. Risk perceptions and their relation to risk behavior. Ann Behav Med. 2004;27:125-130. (Pubitemid 38364892)
38. Klijs B, Otto SJ, Heine RJ, et al. Screening for type 2 diabetes in a high-risk population: Study design and feasibility of a population-based randomized controlled trial. BMC Publ Health. 2012;12:671.
39. Ruige JB, de Neeling JN, Kostense PJ, Bouter LM, Heine RJ. Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care. 1997;20:491-496. (Pubitemid 27143402)
40. Rutten GEHM, de Grauw WJC, Nijpels G, et al.: NHG-Standaard Diabetes mellitus type 2 M01: NHG, 2006.
41. Adriaanse MC, Twisk JW, Dekker JM, et al. Perceptions of risk in adults with a low or high risk profile of developing type 2 diabetes; a cross-sectional population-based study. Patient Educ Couns. 2008;73:307-312.
42. Hildebrandt VH, Chorus AMJ, Stubbe JH: Trendrapport Bewegen en Gezondheid 2008-2009. Leiden, 2010.
43. Spijkerman AM, Adriaanse MC, Dekker JM, et al. Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care. 2002;25:1784-1789. (Pubitemid 41071087)
44. Diabetes Research Center-Albert Einstein College of Medicine: Survey Instruments - Risk Perception Survey for Developing Diabetes (RPS-DD) and Scoring Guide and Psychometrics.
45. Walker EA, Mertz CK, Kalten MR, Flynn J. Risk perception for developing diabetes: Comparative risk judgments of physicians. Diabetes Care. 2003;26:2543-2548. (Pubitemid 37055445)
46. Walker EA, Fisher E, Marrero DG, Mc-Nabb W. Comparative risk judgments among participants in the Diabetes Prevention Program (Abstract). Diabetes. 2001;50:A397. 2001, 50:A397.
47. Walker EA, Caban A, Schechter CB, et al. Measuring comparative risk perceptions in an urban minority population: The risk perception survey for diabetes. Diabetes Educ. 2007;33:103-110.
48. Kim C, McEwen LN, Piette JD, et al. Risk perception for diabetes among women with histories of gestational diabetes mellitus. Diabetes Care. 2007;30:2281-2286. (Pubitemid 47359032)
49. Luister naar uw lichaam: Diabetes kennis quiz. Retrieved June, 2010 from www.luisternaaruwlichaam.nl/Diabetes-kennis-quiz
50. Dorman JS, Valdez R, Liu T, et al. Health beliefs among individuals at increased familial risk for type 2 diabetes: Implications for prevention. Diabetes Res Clin Pract. 2012;96:156-162.
51. Acheson LS, Wang C, Zyzanski SJ, et al. Family history and perceptions about risk and prevention for chronic diseases in primary care: A report from the family healthware impact trial. Genet Med. 2010;12:212-218.
52. Willemsen MC, Wagena EJ, van Schayck CP. The efficacy of smoking cessation methods available in the Netherlands: A systematic review based on Cochrane data. Ned Tijdschr Geneeskd. 2003;147:922-927. (Pubitemid 36560008)
53. Petticrew MP, Sowden AJ, Lister-Sharp D, Wright K. False-negative results in screening programmes: Systematic review of impact and implications. Health Technol Assess. 2000;4:1-120.
54. Feller S, Boeing H, Pischon T. Body mass index, waist circumference, and the risk of type 2 diabetes mellitus: Implications for routine clinical practice. Dtsch Arztebl Int. 2010;107:470-476.
55. Visscher TL, Seidell JC. Time trends (1993-1997) and seasonal variation in body mass index and waist circumference in the Netherlands. Int J Obes Relat Metab Disord. 2004;28:1309-1316. (Pubitemid 39389589)
56. van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ. Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch-Belgian randomised controlled lung cancer screening trial. Thorax. 2010;65:600-605.
57. Polley BA, Jakicic JM, Venditti EM, Barr S, Wing RR. The effects of health beliefs on weight loss in individuals at high risk for NIDDM. Diabetes Care. 1997;20:1533-1538. (Pubitemid 27415029)
58. Hivert MF, Warner AS, Shrader P, Grant RW, Meigs JB. Diabetes risk perception and intention to adopt healthy lifestyles among primary care patients. Diabetes Care. 2009;32:1820-1822.
59. Pinelli NR, Herman WH, Brown MB, Jaber LA. Perceived risk and the willingness to enroll in a diabetes prevention lifestyle intervention in Arab-Americans. Diabetes Res Clin Pract. 2010;90:e27-29.
60. Klein WM, Zajac LE, Monin MM. Worry as a moderator of the association between risk perceptions and quitting intentions in young adult and adult smokers. Ann Behav Med. 2009;38:256-261.
61. Rimal RN, Real K. Perceived risk and efficacy beliefs as motivators of change: Use of the risk perception attitude (RPA) framework to understand health behaviors. Hum Commun Res. 2003;29:370-399.
62. Rimal RN, Brown J, Mkandawire G, et al. Audience segmentation as a social-marketing tool in health promotion: Use of the risk perception attitude framework in HIV prevention in Malawi. Am J Public Health. 2009;99:2224-2229.
63. Harwell TS, Dettori N, Flook BN, et al. Preventing type 2 diabetes: Perceptions about risk and prevention in a population-based sample of adults > or =45 years of age. Diabetes Care. 2001;24:2007-2008.
64. Kemple AM, Zlot AI, Leman RF: Perceived likelihood of developing diabetes among high-risk Oregonians. Prev Chronic Dis. 2005, 2 Spec no: A07.